The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699 · cited 2×
“Receptor tyrosine kinases (RTKs) have emerged as critical mediators of angiogenesis (reviewed in Cheng et al., 2002; Gale and Yancopoulos, 1999; Yancopoulos et al., 2000).”
BackgroundMatrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Self-citationInduction of angiogenesis during the transition from hyperplasia to neoplasia
Folkman, J., Watson, K., Ingber, D., & Hanahan, D. (1989) · Nature · doi:10.1038/339058a0 · Cited by 1,879
Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., & Gasparini, G. (1992) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1875 · Cited by 1,775
Wang, H. U., Chen, Z.-F., & Anderson, D. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81436-1 · Cited by 1,669
Hanahan, D. (1985) · Nature · doi:10.1038/315115a0 · Cited by 1,281
Aslakson, C. J., & Miller, F. R. (1992) · PubMed · Cited by 1,234
Adams, R. H., Wilkinson, G. A., Weiss, C., Diella, F., Gale, N. W., Deutsch, U., Risau, W., & Klein, R. (1999) · Genes & Development · doi:10.1101/gad.13.3.295 · Cited by 1,025
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
Bergers, G., Javaherian, K., Lo, K.-M., Folkman, J., & Hanahan, D. (1999) · Science · doi:10.1126/science.284.5415.808 · Cited by 988 · cited 1×
“Tumor volume was calculated by the following formula: Tumor volume=0.526 width26length (Bergers et al., 1999).”
MethodInfluentialGale, N. W., & Yancopoulos, G. D. (1999) · Genes & Development · doi:10.1101/gad.13.9.1055 · Cited by 784
Davis, S., Gale, N. W., Aldrich, T. H., Maisonpierre, P. C., Lhotak, V., Pawson, T., Goldfarb, M., & Yancopoulos, G. D. (1994) · Science · doi:10.1126/science.7973638 · Cited by 710
Gerety, S. S., Wang, H. U., Chen, Z.-F., & Anderson, D. J. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80342-1 · Cited by 707
Regulated Cleavage of a Contact-Mediated Axon Repellent
Hattori, M., Osterfield, M., & Flanagan, J. G. (2000) · Science · doi:10.1126/science.289.5483.1360 · Cited by 518
Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
Arbiser, J. L., Moses, M. A., Fernandez, C. A., Ghiso, N., Cao, Y., Klauber, N., Frank, D., Brownlee, M., Flynn, E., Parangi, S., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.861 · Cited by 469
EphA2 overexpression causes tumorigenesis of mammary epithelial cells.
Zelinski, D. P., Zantek, N. D., Stewart, J. C., Irizarry, A. R., & Kinch, M. S. (2001) · PubMed · Cited by 463
Eph receptors and ephrins: effectors of morphogenesis
Holder, N., & Klein, R. (1999) · Development · doi:10.1242/dev.126.10.2033 · Cited by 442
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization
Ogawa, K., Pasqualini, R., Lindberg, R. A., Kain, R., Freeman, A. L., & Pasquale, E. B. (2000) · Oncogene · doi:10.1038/sj.onc.1204004 · Cited by 380
Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
Lin, P., Buxton, J. A., Acheson, A., Radziejewski, C., Maisonpierre, P. C., Yancopoulos, G. D., Channon, K. M., Hale, L. P., Dewhirst, M. W., George, S. E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8829 · Cited by 371
Role of B61, the Ligand for the Eck Receptor Tyrosine Kinase, in TNF-α-Induced Angiogenesis
Pandey, A., Shao, H., Marks, R. M., Polverini, P. J., & Dixit, V. M. (1995) · Science · doi:10.1126/science.7536959 · Cited by 363
Li, C.-Y., Shan, S., Huang, Q., Braun, R. D., Lanzen, J., Hu, K., Lin, P., & Dewhirst, M. W. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.143 · Cited by 334
The ephrins and Eph receptors in angiogenesis
Cheng, N., Brantley, D. M., & Chen, J. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00031-4 · Cited by 334
Self-citationDavy, A., Gale, N. W., Murray, E. W., Klinghoffer, R. A., Soriano, P., Feuerstein, C., & Robbins, S. M. (1999) · Genes & Development · doi:10.1101/gad.13.23.3125 · Cited by 296
A transparent access chamber for the rat dorsal skin fold
Papenfuss, H. D., Gross, J. F., Intaglietta, M., & Treese, F. A. (1979) · Microvascular Research · doi:10.1016/0026-2862(79)90039-6 · Cited by 281
Overexpression of the EphA2 tyrosine kinase in prostate cancer
Walker-Daniels, J., Coffman, K., Azimi, M., Rhim, J. S., Bostwick, D. G., Snyder, P., Kerns, B. J., Waters, D. J., & Kinch, M. S. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19991201)41:4<275::aid-pros8>3.0.co;2-t · Cited by 269
E-cadherin regulates the function of the EphA2 receptor tyrosine kinase.
Zantek, N. D., Azimi, M., Fedor‐Chaiken, M., Wang, B., Brackenbury, R. W., & Kinch, M. S. (1999) · PubMed · Cited by 249
Angiogenesis and breast cancer.
Folkman, J. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.441 · Cited by 239
Ephrin-A5 modulates cell adhesion and morphology in an integrin-dependent manner
Davy, A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.20.5396 · Cited by 226
Epithelial Cell Cultures From Normal Glandular Tissue of Mice 2
Owens, R. B., Smith, C. S., & Hackett, A. J. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/53.1.261 · Cited by 212
Huai, J., & Drescher, U. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008127200 · Cited by 180
Holzman, L. B., Marks, R. M., & Dixit, V. M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5830 · Cited by 172
Vascular endothelial growth factor as a marker of tumor endothelium.
Brekken, R. A., Huang, X., King, S. W., & Thorpe, P. E. (1998) · PubMed · Cited by 166
Self-citationHomeobox B3 Promotes Capillary Morphogenesis and Angiogenesis
Myers, C. A., Charboneau, A. L., & Boudreau, N. J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.2.343 · Cited by 152
Nuclear Factor-κB (NF-κB) Regulates Proliferation and Branching in Mouse Mammary Epithelium
Brantley, D. M., Chen, C.-L., Muraoka, R. S., Bushdid, P. B., Bradberry, J. L., Kittrell, F. S., Medina, D., Matrisian, L. M., Kerr, L. D., & Yull, F. E. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.5.1445 · Cited by 140
Self-citationUp-regulation of ephrin-a1 during melanoma progression
Easty, D. J., Hill, S. P., Hsu, M., Fallowfield, M. E., Flørenes, V. A., Herlyn, M., & Bennett, D. C. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991022)84:5<494::aid-ijc8>3.0.co;2-o · Cited by 135
Chen, J., & Ruley, H. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24670 · Cited by 100
Self-citationRadvanyi, F., Christgau, S., Bækkeskov, S., Jolicoeur, C., & Hanahan, D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4223 · Cited by 100
Ephrin-A1 is expressed at sites of vascular development in the mouse
McBride, J. L., & Ruiz, J. C. (1998) · Mechanisms of Development · doi:10.1016/s0925-4773(98)00142-7 · Cited by 88
Noninvasive visualization of tumors in rodent dorsal skin window chambers
Huang, Q., Shan, S., Braun, R. D., Lanzen, J. L., Anyrhambatla, G., Kong, G., Borelli, M., Corry, P. M., Dewhirst, M. W., & Li, C. (1999) · Nature Biotechnology · doi:10.1038/13736 · Cited by 87
Muraoka, R. S., Lenferink, A. E. G., Simpson, J. F., Brantley, D. M., Roebuck, L. R., Yakes, F. M., & Arteaga, C. L. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.917 · Cited by 84
Self-citationKuehn, R. L., Lelkes, P. I., Bloechle, C., et al. (1999) · Pancreas · doi:10.1097/00006676-199901000-00012 · Cited by 79
Weidner, N. (1996) · Cancer treatment and research · doi:10.1007/978-1-4613-1259-8_14 · Cited by 51
Radvanyi, F., Christgau, S., Bækkeskov, S., Jolicoeur, C., & Hanahan, D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4223-4232.1993 · Cited by 26
Cited by
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
Tumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 1,986
Casanovas, O., Hicklin, D. J., Bergers, G., & Hanahan, D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.005 · Cited by 1,621
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Pasquale, E. B. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2806 · Cited by 1,226
Eph receptor signalling casts a wide net on cell behaviour
Pasquale, E. B. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1662 · Cited by 1,017
Metadata
- Authors
- Brantley, D. M., Cheng, N., Thompson, E. J., Lin, Q., Brekken, R. A., Thorpe, P. E., Muraoka, R. S., Cerretti, D. P., Pozzi, A., Jackson, D., Lin, C., & Chen, J.
- Venue
- Oncogene
- Published
- 2002-10-09
- Volume
- 21
- Issue
- 46
- Pages
- 7011-7026
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1994137567
- Cited by
- 316
- References
- 44
- FWCI
- 7.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.